No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 24, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Valuation correction creating stock-specific opportunities, not sectoral bets: Ashwini Agarwal

by TheAdviserMagazine
3 months ago
in Business
Reading Time: 3 mins read
A A
Valuation correction creating stock-specific opportunities, not sectoral bets: Ashwini Agarwal
Share on FacebookShare on TwitterShare on LInkedIn


“I don’t think I can identify broad sectors at this point, but I can identify individual stocks. Outside of the financial sector, maybe domestic healthcare looks okay. Some other domestic consumption names also seem fine. There’s a smattering of opportunities from a sector perspective, but on a bottom-up basis, there are quite a few attractive picks,” says Ashwini Agarwal, Founder, Demeter Advisors.

Other than the sectors you’ve just mentioned—NBFCs, MFIs, and select consumption plays—given the kind of consolidation we’ve seen in the markets recently and the rather rangebound movement, are there any sectors that you think look attractive right now in terms of valuations, having seen some correction? Or fundamentally, are there any other sectors or pockets that could, given the current volatility, act as a sort of safety net for investors?Ashwini Agarwal: My sense is that this is not the time to be sector-oriented. It’s a time to take a very bottom-up, individual stock approach. Again, in the short run, it’s important to temper return expectations—but keep your focus on the medium term.

For example, take textile exports. Obviously, they’ll get hit if these tariffs are imposed, especially for companies with a high exposure to the United States in their sales mix. If stock prices react negatively, you might actually get an opportunity to buy them. But you’ll have to ride out a couple of bad quarters—that goes without saying.

So, I don’t think I can identify broad sectors at this point, but I can identify individual stocks. Outside of the financial sector, maybe domestic healthcare looks okay. Some other domestic consumption names also seem fine. There’s a smattering of opportunities from a sector perspective, but on a bottom-up basis, there are quite a few attractive picks.

Live Events

You’ve shared your views on the pharma space, but another sector that could be in focus is electronics, which—for now—has seen some exemptions. A specific example is Apple, which has a manufacturing base in India. Trump has been demanding a shift, and just yesterday, they committed to a large investment in the US. With this whole tariff uncertainty, along with pharma, do you think the manufacturing and EMS (Electronics Manufacturing Services) story in India could come under question? Could this be a concern for investors?Ashwini Agarwal: I really can’t say for sure because it’s unclear whether the tariffs are here to stay, or if this is simply part of ongoing negotiations between the United States and India. We don’t yet know how the dust will settle.That said, in the long run, we have to look beyond the immediate term. India’s cost advantage in manufacturing is real and here to stay. If our policy framework continues to support it, then eventually, water will find its own level—and global manufacturers will seek a cost-competitive production base. That fact doesn’t change.So, if this current noise gives us an opportunity to buy EMS companies at better prices, that would be a welcome development. Frankly, I’ve found EMS companies to be quite expensive so far. I tend to have a value bias, so I haven’t really explored that space much yet. But yes, if stock prices weaken due to this noise, it could present an opportunity. In the long term, India’s competitive advantage will remain intact.

Apart from Trump’s commentary, what’s on your watchlist right now? Not just earnings, but perhaps the dollar-rupee or other global markets?Ashwini Agarwal: At the moment, I’m really focused on the earnings season. I’m tracking companies that are improving their revenue, margin, and earnings profile both quarter-on-quarter and year-on-year—where the improvement looks sustainable. Those stocks will perform well.

One theme worth focusing on is earnings recovery—companies that have gone through a downcycle over the last two to three years, but whose earnings are now starting to bottom out. Those stocks should do very well. That’s what I’m searching for. My sense is that in an overall tepid earnings environment, companies delivering 15–20% earnings growth will see significant valuation expansion. That’s where my attention is right now.



Source link

Tags: AgarwalAshwiniBetscorrectionCreatingOpportunitiessectoralstockspecificvaluation
ShareTweetShare
Previous Post

Crude Oil: Supply-Side Pressures, Tariff Risks May Trigger Break Below Key Support

Next Post

Built for the Future: Gen Z’s Shift Toward Skilled Trades and Franchising

Related Posts

edit post
Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

by TheAdviserMagazine
October 24, 2025
0

Prices of essential goods have sharply increased in both Pakistan and Afghanistan after border closures disrupted cross-border trade between the...

edit post
Goldman aims for ‘PE returns’ with new ETF

Goldman aims for ‘PE returns’ with new ETF

by TheAdviserMagazine
October 23, 2025
0

Goldman Sachs Asset Management is teaming up with MSCI Inc. to launch an exchange-traded fund that aims to deliver returns...

edit post
Tesla’s weak earnings show how the ‘Musk Magic’ Premium is inflating its share price

Tesla’s weak earnings show how the ‘Musk Magic’ Premium is inflating its share price

by TheAdviserMagazine
October 23, 2025
0

Over the past year, on the day after Tesla unveils its latest quarterly report, this writer has calculated a metric...

edit post
Former BLS chief warns Powell is “flying blind” at a pivotal time for the Fed

Former BLS chief warns Powell is “flying blind” at a pivotal time for the Fed

by TheAdviserMagazine
October 23, 2025
0

The Federal Reserve faces an unprecedented challenge as it prepares to set interest rates next week—making its decision with almost no...

edit post
With  trillion pay package on the line, Elon Musk blasts influential firms telling shareholders to reject it: ‘Those guys are corporate terrorists’

With $1 trillion pay package on the line, Elon Musk blasts influential firms telling shareholders to reject it: ‘Those guys are corporate terrorists’

by TheAdviserMagazine
October 23, 2025
0

Elon Musk stole the show in the final minutes of Tesla’s Wednesday earnings call to label the advisory firms pushing...

edit post
One Nation, One Workforce: Govt plans integrated system to ensure social-security portability for all workers

One Nation, One Workforce: Govt plans integrated system to ensure social-security portability for all workers

by TheAdviserMagazine
October 23, 2025
0

New Delhi: The ministry of labour and employment plans to build a unified One Nation Integrated Workforce Architecture that will...

Next Post
edit post
Built for the Future: Gen Z’s Shift Toward Skilled Trades and Franchising

Built for the Future: Gen Z’s Shift Toward Skilled Trades and Franchising

edit post
AI tool of the week: UK-based Tracelight secures €3M to make analysts superhuman in spreadsheets 

AI tool of the week: UK-based Tracelight secures €3M to make analysts superhuman in spreadsheets 

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Links 10/23/2025 | naked capitalism

Links 10/23/2025 | naked capitalism

0
edit post
Ikea CEO Jesper Brodin may get chance to run UN division like a business

Ikea CEO Jesper Brodin may get chance to run UN division like a business

0
edit post
SBI-Owned B2C2 Announces Zero-Fee Stablecoin Swap Platform for Institutions

SBI-Owned B2C2 Announces Zero-Fee Stablecoin Swap Platform for Institutions

0
edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

0
edit post
WEP/GPO Repealed—Now What? 6 Steps for Teachers, Firefighters, and Public Workers to Recheck Benefits in 2025

WEP/GPO Repealed—Now What? 6 Steps for Teachers, Firefighters, and Public Workers to Recheck Benefits in 2025

0
edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

0
edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

October 24, 2025
edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

October 24, 2025
edit post
Hyperliquid Price Breaks Key Resistance as B Fundraising and IPO Plans Gain Traction

Hyperliquid Price Breaks Key Resistance as $1B Fundraising and IPO Plans Gain Traction

October 24, 2025
edit post
Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

October 24, 2025
edit post
Europe Fears A US Civil War – Whiskey Rebellion To Now

Europe Fears A US Civil War – Whiskey Rebellion To Now

October 24, 2025
edit post
US Dollars Go On-Chain as Uphold and Vast Bank Fuse Banking With Blockchain

US Dollars Go On-Chain as Uphold and Vast Bank Fuse Banking With Blockchain

October 23, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!
  • China strikes conciliatory tone ahead of expected Trump-Xi meeting
  • Hyperliquid Price Breaks Key Resistance as $1B Fundraising and IPO Plans Gain Traction
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.